|
"楊志新"的相关文件
显示项目 81-90 / 209 (共21页)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每页显示[10|25|50]项目
| 國立臺灣大學 |
2013 |
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas
|
Wu, Pei-Fang; Huang, Wen-Chang; Yang, James Chih-Hsin; Lu, Yen-Shen; Shih, Jin-Yuan; Wu, Shang-Gin; Lin, Ching-Hung; Cheng, Ann-Lii; 楊志新; 盧彥伸; 鄭安理; 吳尚俊; 施金元; 林璟宏 |
| 國立臺灣大學 |
2013 |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai, Tzu-Hsiu; Yang, Ching-Yao; Ho, Chao-Chi; Liao, Wei-Yu; Jan, I-Shiow; Chen, Kuan-Yu; Wang, Jann-Yuan; Ruan, Sheng-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊志新; 詹一秀; 楊泮池; 廖唯昱; 陳冠宇; 余忠仁; 何肇基; 阮聖元; 蔡子修; 王振源; 施金元 |
| 國立臺灣大學 |
2013 |
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
|
Shao, Yu-Yun; Shau, Wen-Yi; Lin, Zhong-Zhe; Chen, Ho-Min; Kuo, Raymond; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲 |
| 國立臺灣大學 |
2013 |
Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Hsu, Chiun; Shao, Yu-Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2013 |
Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
|
Lee, Chee Khoon; Brown, Chris; Gralla, Richard J.; Hirsh, Vera; Thongprasert, Sumitra; Tsai, Chun-Ming; Tan, Eng Huat; Ho, James Chung-Man; Chu, Da Tong; Zaatar, Adel; Osorio Sanchez, Jemela Anne; Vu, Vu Van; Au, Joseph Siu Kie; Inoue, Akira; Lee, Siow Ming; Gebski, Val; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2013 |
Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study
|
Chang, Gee-Chen; Tsai, Chun-Ming; Hsia, Te-Chun; Yang, Chih-Hsin; Abdulnabi, Radhi; Blair, Julie M.; Linn, Carlos; 楊志新 |
| 國立臺灣大學 |
2013 |
MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib
|
Huang, Ming-Hung; Lee, Jih-Hsiang; Chang, Ya-Ju; Tsai, Hsin-Hui; Lin, Yu-Lin; Lin, Anya Maan-Yuh; Yang, James Chih-Hsin; 楊志新; 林育麟; 李日翔 |
| 國立臺灣大學 |
2013 |
Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations
|
Yang, James Chih-Hsin; Hirsh, Vera; Schuler, Martin; Yamamoto, Nobuyuki; O'Byrne, Kenneth J.; Mok, Tony S. K.; Zazulina, Victoria; Shahidi, Mehdi; Lungershausen, Juliane; Massey, Dan; Palmer, Michael; Sequist, Lecia V.; 楊志新 |
| 國立臺灣大學 |
2013 |
Epidermal growth factor receptor (EGFR)-mediated adverse events (AEs) in patients (pts) with EGFR mutation positive (EGFR M plus ) non-small cell lung cancer treated with afatinib
|
Yang, J. Chih-Hsin; Sequist, L.; O'Byrne, K.; Schuler, M.; Mok, T.; Geater, S.; Massey, D.; O'Brien, D.; Zazulina, V.; Wu, Y. L.; 楊志新 |
| 國立臺灣大學 |
2013 |
EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer
|
Kao, Hsiang-Fong; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 高祥豐 |
显示项目 81-90 / 209 (共21页)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每页显示[10|25|50]项目
|
